The dual effect of CA1 NMDA receptor modulation on ACPA-induced amnesia in step-down passive avoidance learning task

European Neuropsychopharmacology

Volumn 25, Issue 4, 2015, Pages 557-565

  Nasehi, Mohammad ^a   Amin Yavari, Samaneh ^b   Ebrahimi Ghiri, Mohaddeseh ^c   Torabi Nami, Mohammad ^d,e   Zarrindast, Mohammad Reza ^a,f,g,h  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF ZANJAN   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

Author keywords

ACPA; AM251; D AP7; Mice; NMDA; Passive avoidance learning

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 AMINO 7 PHOSPHONOHEPTANOIC ACID; ARACHIDONYLCYCLOPROPYLAMIDE; CANNABINOID 1 RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG; 2 AMINO 5 PHOSPHONOVALERIC ACID; 2-AMINO-7-PHOSPHONOHEPTANOIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR AGONIST; N METHYLASPARTIC ACID; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADULT; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; EXPLORATORY BEHAVIOR; HIPPOCAMPAL CA1 REGION; HOLE BOARD TEST; INFORMATION RETRIEVAL; LEARNING; LOCOMOTION; MALE; MEMORY DISORDER; MICROINJECTION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ELECTROSHOCK; METABOLISM; PATHOLOGY;

2-AMINO-5-PHOSPHONOVALERATE; AMNESIA; ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONIC ACIDS; AVOIDANCE LEARNING; CA1 REGION, HIPPOCAMPAL; CANNABINOID RECEPTOR AGONISTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; MALE; MICE; MICROINJECTIONS; N-METHYLASPARTATE; PIPERIDINES; PYRAZOLES; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84928212532     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.01.004     Document Type: Article

References (36)

1. Alger B.E., Pitler T.A. Retrograde signaling at GABAA-receptor synapses in the mammalian CNS. Trends Neurosci. 1995, 18:333-340.
2. Bartlett T.E., Bannister N.J., Collett V.J., Dargan S.L., Massey P.V., Bortolotto Z.A., Fitzjohn S.M., Bashir Z.I., Collingridge G.L., Lodge D. Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus. Neuropharmacology 2007, 52:60-70.
3. Bashir Z.I., Collingridge G.L. Synaptic plasticity: long-term potentiation in the hippocampus. Curr. Opin. Neurobiol. 1992, 2:328-335.
4. Bohme G.A., Laville M., Ledent C., Parmentier M., Imperato A. Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 2000, 95:5-7.
5. Campolongo P., Ratano P., Manduca A., Scattoni M.L., Palmery M., Trezza V., Cuomo V. The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness. Front. Behav. Neurosci. 2012, 6:11.
6. Carlson G., Wang Y., Alger B.E. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci. 2002, 5:723-724.
7. Chegini H.R., Nasehi M., Zarrindast M.R. Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice. Behav. Brain Res. 2014, 261:114-126.
8. Chevaleyre V., Castillo P.E. Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 2003, 38:461-472.
9. Corlew R., Wang Y., Ghermazien H., Erisir A., Philpot B.D. Developmental switch in the contribution of presynaptic and postsynaptic NMDA receptors to long-term depression. J. Neurosci. 2007, 27:9835-9845.
10. Da S., Takahashi R.N. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26:321-325.
11. Davies S.N., Pertwee R.G., Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 2002, 42:993-1007.
12. de Oliveira Alvares L., Genro B.P., Vaz Breda R., Pedroso M.F., Da Costa J.C., Quillfeldt J.A. AM251, a selective antagonist of the CB1 receptor, inhibits the induction of long-term potentiation and induces retrograde amnesia in rats. Brain Res. 2006, 1075:60-67.
13. Han J., Kesner P., Metna-Laurent M., Duan T., Xu L., Georges F., Koehl M., Abrous D.N., Mendizabal-Zubiaga J., Grandes P., Liu Q., Bai G., Wang W., Xiong L., Ren W., Marsicano G., Zhang X. Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 2012, 148:1039-1050.
14. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U S A 1990, 87:1932-1936.
15. Hoffman A.F., Laaris N., Kawamura M., Masino S.A., Lupica C.R. Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J. Neurosci. 2010, 30:545-555.
16. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 2009, 89:309-380.
17. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T., Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 2006, 26:2991-3001.
18. Lamprecht R., LeDoux J. Structural plasticity and memory. Nat. Rev. Neurosci. 2004, 5:45-54.
19. Lichtman A.H., Dimen K.R., Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 1995, 119:282-290.
20. Malenka R.C., Nicoll R.A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci. 1993, 16:521-527.
21. Marsicano G., Lutz B. Neuromodulatory functions of the endocannabinoid system. J. Endocrinol. Investig. 2006, 29:27-46.
22. Mazzola C., Medalie J., Scherma M., Panlilio L.V., Solinas M., Tanda G., Drago F., Cadet J.L., Goldberg S.R., Yasar S. Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. Learn. Mem. 2009, 16:332-337.
23. Misner D.L., Sullivan J.M. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci. 1999, 19:6795-6805.
24. Morena M., Campolongo P. The endocannabinoid system: an emotional buffer in the modulation of memory function. Neurobiol. Learn. Mem. 2014, 112:30-43.
25. Morishita W., Lu W., Smith G.B., Nicoll R.A., Bear M.F., Malenka R.C. Activation of NR2B-containing NMDA receptors is not required for NMDA receptor-dependent long-term depression. Neuropharmacology 2007, 52:71-76.
26. Nasehi M., Amin Yavari S., Zarrindast M.R. Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice. Psychopharmacology 2013, 227:553-566.
27. Otmakhova N.A., Otmakhov N., Lisman J.E. Pathway-specific properties of AMPA and NMDA-mediated transmission in CA1 hippocampal pyramidal cells. J. Neurosci. 2002, 22:1199-1207.
28. Pamplona F.A., Takahashi R.N. WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neurosci. Lett. 2006, 397:88-92.
29. Paxinos G., Franklin K.B.J The Mouse Brain in Stereotaxic Coordinates 2001, Academic Press, San Diego, California, USA. 2nd ed.
30. Pertwee R.G., Ross R.A. Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fat. Acids 2002, 66:101-121.
31. Riedel G., Davies S.N. Cannabinoid function in learning, memory and plasticity. Handb. Exp. Pharmacol. 2005, (168):445-477.
32. Riedel G., Platt B., Micheau J. Glutamate receptor function in learning and memory. Behav. Brain Res. 2003, 140:1-47.
33. Rodriguez-Moreno A., Kohl M.M., Reeve J.E., Eaton T.R., Collins H.A., Anderson H.L., Paulsen O. Presynaptic induction and expression of timing-dependent long-term depression demonstrated by compartment-specific photorelease of a use-dependent NMDA receptor antagonist. J. Neurosci. 2011, 31:8564-8569.
34. Shipton O.A., Paulsen O. GluN2A and GluN2B subunit-containing NMDA receptors in hippocampal plasticity. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2014, 369:20130163.
35. Terranova J.P., Michaud J.C., Le Fur G., Soubrie P. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch. Pharmacol. 1995, 352:576-579.
36. Zhang W.N., Bast T., Feldon J. The ventral hippocampus and fear conditioning in rats: different anterograde amnesias of fear after infusion of N-methyl-d-aspartate or its noncompetitive antagonist MK-801 into the ventral hippocampus. Behav. Brain Res. 2001, 126:159-174.